drugset / Trial / NCT01219049

L-Tyrosine Supplementation in Patients With Fibromyalgia

NCT01219049 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

Patients in the study, who have a diagnosis of fibromyalgia, will be randomly assigned to take the amino acid L-tyrosine or placebo (blank pill) for 3 weeks. They will fill out questionnaires about their symptoms and see if they have any improvement. The investigators hypothesis is that taking tyrosine will help alleviate the symptoms of fibromyalgia.

Timeline

Start
2010-01
Primary completion
2011-01
Completion
2011-01

Outcome

Outcome not reported

Stopped: “Due to FDA comments, changes required unavailable resources. There are no results for this study.”

Drugs

EvaluationDrugModalityDoseRoute
Subject tyrosine Unknown 1000 mg —
Subject tyrosine Unknown 2000 mg —

Indications